Bonnie E Ronish1, David J Couper2, Igor Z Barjaktarevic, Christopher B Cooper3,4, Richard E Kanner1, Cheryl S Pirozzi1, Victor Kim5, James M Wells6, MeiLan K Han7, Prescott G Woodruff8, Victor E Ortega9, Stephen P Peters10, Eric A Hoffman11, Russell G Buhr3,12, Brett A Dolezal3, Donald P Tashkin3, Theodore G Liou1, Lori A Bateman2, Joyce D Schroeder13, Fernando J Martinez14, R Graham Barr15, Nadia N Hansel16, Alejandro P Comellas17, Stephen I Rennard18, Mehrdad Arjomandi8,19, Robert Paine Iii1. 1. Division of Respiratory, Critical Care and Occupational Pulmonary Medicine, University of Utah, Salt Lake City, Utah, United States. 2. Department of Biostatistics, The University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, United States. 3. Division of Pulmonary and Critical Care, Department of Medicine, David Geffen School of Medicine, University of California at Los Angeles, Los Angeles, California, United States. 4. Department of Physiology, David Geffen School of Medicine, University of California at Los Angeles, Los Angeles, California, United States. 5. Department of Thoracic Medicine and Surgery, Lewis Katz School of Medicine, Temple University Hospital, Philadelphia, Pennsylvania, United States. 6. Division of Pulmonary, Allergy, and Critical Care Medicine, University of Alabama at Birmingham, Birmingham, Alabama, United States. 7. Division of Pulmonary and Critical Care Medicine, University of Michigan, Ann Arbor, Michigan, United States. 8. Department of Medicine, University of California San Francisco, San Francisco, California, United States. 9. Division of Internal Medicine, Wake Forest School of Medicine, Winston Salem, North Carolina, United States. 10. Division of Internal Medicine, Wake Forest University Health Sciences, Winston-Salem, North Carolina, United States. 11. Department of Radiology, Division of Physiologic Imaging, University of Iowa Carver College of Medicine, Iowa City, Iowa, United States. 12. Center for the Study of Healthcare Innovation, Implementation, and Policy, VA Health Services Research and Development, Greater Los Angeles Veterans Affairs Healthcare System, Los Angeles, California, United States. 13. Division of Radiology and Imaging Sciences, University of Utah, Salt Lake City, Utah, United States. 14. Division of Pulmonary and Critical Care, Weill Cornell Medicine, New York, New York, United States. 15. Department of Internal Medicine, Columbia University, New York, New York, United States. 16. Division of Pulmonary and Critical Care Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland, United States. 17. Department of Internal Medicine, Division of Pulmonary, Critical Care and Occupational Medicine, University of Iowa, Iowa City, Iowa, United States. 18. Department of Internal Medicine, University of Nebraska Medical Center, Omaha, Nebraska, United States. 19. San Francisco Veterans Affairs Healthcare System, San Francisco, California, United States.
Abstract
BACKGROUND: Forced expiratory volume in 1 second (FEV1) is central to the diagnosis of chronic obstructive pulmonary disease (COPD) but is imprecise in classifying disease burden. We examined the potential of the maximal mid-expiratory flow rate (forced expiratory flow rate between 25% and 75% [FEF25%-75%]) as an additional tool for characterizing pathophysiology in COPD. OBJECTIVE: To determine whether FEF25%-75% helps predict clinical and radiographic abnormalities in COPD. STUDY DESIGN AND METHODS: The SubPopulations and InteRediate Outcome Measures In COPD Study (SPIROMICS) enrolled a prospective cohort of 2978 nonsmokers and ever-smokers, with and without COPD, to identify phenotypes and intermediate markers of disease progression. We used baseline data from 2771 ever-smokers from the SPIROMICS cohort to identify associations between percent predicted FEF25%-75% (%predFEF25%-75%) and both clinical markers and computed tomography (CT) findings of smoking-related lung disease. RESULTS: Lower %predFEF25-75% was associated with more severe disease, manifested radiographically by increased functional small airways disease, emphysema (most notably with homogeneous distribution), CT-measured residual volume, total lung capacity (TLC), and airway wall thickness, and clinically by increased symptoms, decreased 6-minute walk distance, and increased bronchodilator responsiveness (BDR). A lower %predFEF25-75% remained significantly associated with increased emphysema, functional small airways disease, TLC, and BDR after adjustment for FEV1 or forced vital capacity (FVC). INTERPRETATION: The %predFEF25-75% provides additional information about disease manifestation beyond FEV1. These associations may reflect loss of elastic recoil and air trapping from emphysema and intrinsic small airways disease. Thus, %predFEF25-75% helps link the anatomic pathology and deranged physiology of COPD. JCOPDF
BACKGROUND: Forced expiratory volume in 1 second (FEV1) is central to the diagnosis of chronic obstructive pulmonary disease (COPD) but is imprecise in classifying disease burden. We examined the potential of the maximal mid-expiratory flow rate (forced expiratory flow rate between 25% and 75% [FEF25%-75%]) as an additional tool for characterizing pathophysiology in COPD. OBJECTIVE: To determine whether FEF25%-75% helps predict clinical and radiographic abnormalities in COPD. STUDY DESIGN AND METHODS: The SubPopulations and InteRediate Outcome Measures In COPD Study (SPIROMICS) enrolled a prospective cohort of 2978 nonsmokers and ever-smokers, with and without COPD, to identify phenotypes and intermediate markers of disease progression. We used baseline data from 2771 ever-smokers from the SPIROMICS cohort to identify associations between percent predicted FEF25%-75% (%predFEF25%-75%) and both clinical markers and computed tomography (CT) findings of smoking-related lung disease. RESULTS: Lower %predFEF25-75% was associated with more severe disease, manifested radiographically by increased functional small airways disease, emphysema (most notably with homogeneous distribution), CT-measured residual volume, total lung capacity (TLC), and airway wall thickness, and clinically by increased symptoms, decreased 6-minute walk distance, and increased bronchodilator responsiveness (BDR). A lower %predFEF25-75% remained significantly associated with increased emphysema, functional small airways disease, TLC, and BDR after adjustment for FEV1 or forced vital capacity (FVC). INTERPRETATION: The %predFEF25-75% provides additional information about disease manifestation beyond FEV1. These associations may reflect loss of elastic recoil and air trapping from emphysema and intrinsic small airways disease. Thus, %predFEF25-75% helps link the anatomic pathology and deranged physiology of COPD. JCOPDF
Authors: M R Miller; J Hankinson; V Brusasco; F Burgos; R Casaburi; A Coates; R Crapo; P Enright; C P M van der Grinten; P Gustafsson; R Jensen; D C Johnson; N MacIntyre; R McKay; D Navajas; O F Pedersen; R Pellegrino; G Viegi; J Wanger Journal: Eur Respir J Date: 2005-08 Impact factor: 16.671
Authors: Surya P Bhatt; Pallavi P Balte; Joseph E Schwartz; Patricia A Cassano; David Couper; David R Jacobs; Ravi Kalhan; George T O'Connor; Sachin Yende; Jason L Sanders; Jason G Umans; Mark T Dransfield; Paulo H Chaves; Wendy B White; Elizabeth C Oelsner Journal: JAMA Date: 2019-06-25 Impact factor: 56.272
Authors: Eric A Hoffman; Firas S Ahmed; Heather Baumhauer; Mathew Budoff; J Jeffrey Carr; Richard Kronmal; S Reddy; R Graham Barr Journal: Ann Am Thorac Soc Date: 2014-07
Authors: Afroditi K Boutou; Zaid Zoumot; Arjun Nair; Claire Davey; David M Hansell; Athanasios Jamurtas; Michael I Polkey; Nicholas S Hopkinson Journal: COPD Date: 2015-09-23 Impact factor: 2.409
Authors: Wayne H Anderson; Jae Wook Ha; David J Couper; Wanda K O'Neal; R Graham Barr; Eugene R Bleecker; Elizabeth E Carretta; Christopher B Cooper; Claire M Doerschuk; M Bradley Drummond; MeiLan K Han; Nadia N Hansel; Victor Kim; Eric C Kleerup; Fernando J Martinez; Stephen I Rennard; Donald Tashkin; Prescott G Woodruff; Robert Paine; Jeffrey L Curtis; Richard E Kanner Journal: PLoS One Date: 2017-09-21 Impact factor: 3.240
Authors: Erica Bazzan; Umberto Semenzato; Graziella Turato; Davide Biondini; Pablo Cubero; Marta Marin-Oto; Marta Forner; Mariaenrica Tinè; Alvise Casara; Simonetta Baraldo; Paolo Spagnolo; Jose M Marin; Marina Saetta; Manuel G Cosio Journal: ERJ Open Res Date: 2022-06-27